Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabetes.
The Human Heart May Have a Hidden Ability to Repair Itself Nov. 21, 2024 — After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving ...